Best Kidney Biopsy Doctors Abroad

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Özcan Uzun is a nephrology specialist at Medicalpoint International Hospital in İzmir. He treats complex kidney conditions, including diabetic kidney disease and glomerulonephritis. Dr. Uzun earned his medical degree from Atatürk University. He completed his internal medicine and nephrology training at Dokuz Eylül University. He is a member of the Turkish Nephrology Association and the Izmir Medical Chamber.

• Specializes in hemodialysis and hypertension management.
• Treats chronic kidney failure, Fabry disease, and vasculitis.
• Manages kidney disease related to heart failure and hyponatremia.
• Works at a JCI-accredited hospital featuring a specialized robotic surgery center.

The doctor is a highly skilled gynecologist with a specialized focus in oncogynecology, providing expert care in the diagnosis and treatment of gynecological cancers. With extensive experience in both surgical and non-surgical approaches, the doctor is committed to advancing women's health through innovative treatments and compassionate care.

Dr. Choi Han Yong leads the Urology Department at Samsung Medical Center. He oversees specialty care for patients requiring a kidney biopsy.

• Serves as the Head of Urology at a top-tier medical institution
• Specializes in oncosurgery focusing on urological cancers
• Leads a department recognized for high-level diagnostic accuracy
• Expert in identifying urological conditions through surgical and biopsy techniques

Dr. Ahn Jin Seok is a specialized oncologist at Samsung Medical Center in Seoul. His expertise supports patients needing a kidney biopsy to identify or grade renal tumors.

• Practices at Samsung Medical Center – a top-ranked facility for cancer care in Asia
• Focuses on oncology – helps patients navigate diagnosis and treatment for kidney cancer
• Works within a major medical center recognized for advanced diagnostic technology

Professor Serkan Deveci is a specialized urologist and surgeon at Medical Park Göztepe Hospital. He focuses on kidney biopsy for diagnosing urological cancers.

• Treats kidney and prostate cancers at a major Istanbul hospital complex
• Performs nephrectomies – surgical removal of kidney tissue or the whole organ
• Uses spiral CT scans to analyze urinary stone composition before treatment
• Section Editor at UpToDate – an international clinical decision resource for doctors
• Published over 20 papers in international medical journals

The doctor is an accomplished oncogynecologist with extensive experience in treating gynecological cancers. Specializing in advanced surgical techniques and personalized treatment plans, the doctor has contributed significantly to improving patient outcomes. With numerous publications in peer-reviewed journals, the doctor is recognized for expertise in minimally invasive procedures and has been a keynote speaker at international conferences.

The doctor holds board certification in gynecologic oncology and is actively involved in clinical research, focusing on innovative therapies and early detection methods. The doctor is affiliated with a leading medical institution and collaborates with multidisciplinary teams to provide comprehensive care.

The doctor is a gynecologist specializing in endoscopic and laparoscopic operations. With a focus on minimally invasive surgical techniques, the doctor is skilled in performing advanced procedures that enhance patient recovery and outcomes. The doctor has extensive experience in handling complex gynecological cases, utilizing cutting-edge technology to provide optimal care.

The doctor is a highly experienced mammologist, specializing in breast surgery. With a focus on innovative surgical techniques, the doctor leads the Breast Surgery Department, ensuring top-tier patient care and outcomes. The doctor is recognized for contributions to breast cancer treatment and has published numerous research articles in prestigious medical journals. The doctor is also involved in clinical trials aimed at improving breast cancer therapies and has received multiple awards for excellence in surgical practice and patient care.

The doctor is a highly experienced medical professional with over 20 years of experience at the Hadassah Medical Center. Graduating from the Faculty of Medicine of the Hebrew University of Jerusalem in 1996, the doctor specializes in the diagnosis and treatment of temporomandibular joint disorders. The doctor is proficient in English, Hebrew, and Russian, enhancing communication with a diverse patient population.

Professor Yoram Kluger is a leading specialist in surgical oncology at Rambam Medical Center. His expertise supports accurate kidney biopsy procedures for the diagnosis of complex tumors.

• Heads the Department of General Surgery at Rambam – a major university hospital
• Professor of surgery at the Technion – Israel Institute of Technology
• Specializes in oncosurgery focusing on the diagnosis and removal of cancerous growths
• Former fellow in trauma and critical care at Allegheny General Hospital in the USA

Dr. Karen Drumea is a senior oncologist and radiotherapy specialist at Rambam Medical Center.

• Specializes in cancer treatment and diagnostic protocols
• Coordinates complex care at a leading Israeli government hospital
• Focuses on oncology where kidney biopsy results guide treatment
• Expert in identifying tumor types through advanced imaging and sampling

Dr. Gilad Amiel leads the Urology Department at Rambam Medical Center. He is an expert oncosurgeon specializing in urological diagnostics and cancer care.

• Heads the urology division – oversees surgical and diagnostic procedures for kidney health
• Specializes in oncosurgery – treats cancers of the urinary tract and kidneys
• Directs patient care at Rambam – a leading Israeli government medical center

Dr. Lee Kyu Taek is a gastroenterologist at Samsung Medical Center in Seoul. He specializes in treating pancreatic, bile duct, and gallbladder cancers. Dr. Lee serves as a professor at the Department of Gastroenterology. He trained at Stanford University School of Medicine in the United States.

• Expertise in surgical oncology procedures like Whipple surgery.
• Performs distal pancreatectomy and complex pancreatic biopsies.
• Completed medical training in South Korea, Japan, and the USA.
• Member of the Korean Society of Gastrointestinal Endoscopy.

Dr. Jong Kyun Lee is a gastroenterologist at Samsung Medical Center in Seoul. He focuses on pancreatic, bile duct, and gallbladder cancers. Dr. Lee serves as a professor and treats complex conditions like pancreatitis and gallstones. He completed medical training at Seoul National University and the University of California.

• Performs specialized procedures including Whipple surgery and distal pancreatectomy.
• Maintains membership in the Korean Society of Gastrointestinal Endoscopy.
• Treats patients at a clinic ranked among the World's Best Smart Hospitals by Newsweek.
• Member of the Korean Pancreatobiliary Association and the Society of Gastroenterology.

Dr. Antonio de Lacy Fortuny is a surgical pioneer at Hospital Quiron Barcelona. He has performed 15,000+ surgeries and conducts over 1,000 minimally invasive procedures every year. He famously performed the world’s first gallbladder removal through the mouth. Dr. de Lacy also developed the TaTME technique for rectal cancer treatment.

• Serves as President of the Association of Surgeons-Endoscopists in Europe.
• First surgeon in the world to perform a transanal large intestine removal.
• Pioneered the NOTES method using natural openings to access the abdominal cavity.
• Specializes in robotic and laparoscopic surgery for colon, rectal, and esophageal cancer.

Dr. Zulfu Sertkaya is an associate professor and andrologist at Andro Expertise in Istanbul. He holds the FEBU title from the European Association of Urology. Dr. Sertkaya focuses on male health, sexual function, and aesthetic urological procedures. He treats patients at his clinic and performs surgeries at affiliated hospitals.

• Earned Fellow of the European Board of Urology (FEBU) status.
• Specialize in andrology, male sexual health, and aesthetic urology.
• Performs penile implant surgery and varicocelectomy for infertility.
• Works at a clinic accredited by the Turkish Medical Association.

Dr. Brenda Pastrana is a surgical oncologist at the JCI-accredited Galenia Hospital in Cancún. She specializes in breast, thyroid, and digestive system cancers. Dr. Pastrana is board-certified by CONACEM. She holds a medical degree from the Universidad Autónoma de México.

• Performs mastectomies, liver resections, and complex colon cancer surgeries.
• Treats patients at a facility holding Accreditation Canada Diamond Status.
• Serves as a university teacher at Universidad Anáhuac.
• Member of the Mexican Society of Oncology (SMEO).

Dr. Gokhan Yilmaz is a general surgeon at Medipol University Pendik Hospital in Istanbul. He specializes in colorectal, gastrointestinal, and bariatric surgery. Dr. Yilmaz previously served as an Assistant Professor at Istanbul Medipol University. He trained at Okmeydanı Training and Research Hospital, a top Turkish medical institution.

• Performs complex procedures like gastric sleeve, gastric bypass, and gastric balloon.
• Treats conditions including inguinal hernias, pancreatic cysts, and fibrocystic breast disease.
• Conducted surgical research and trained new surgeons as a university faculty member.
• Works at a facility that earned 95.4 out of 96.4 points for healthcare quality.

Dr. Gurkan Danisan is an Associate Professor and interventional radiologist at Medipol Acibadem District Hospital. He specializes in neurovascular, oncologic, and peripheral arterial interventions. Dr. Danisan performs minimally invasive procedures like angiography and guided biopsies for various conditions. He works at a JCI-accredited facility using robotic technology for patient care.

• Holds memberships in the European Society of Neuroradiology and ESR.
• Is a member of the Cardiovascular and Interventional Radiological Society of Europe.
• Served as an Assistant Professor at Sakarya University Training and Research Hospital.
• Treats complex vascular diseases and performs precise nonvascular interventions.